COVID news live: UK launches interim ‘vaccine-proof’ plan so Britons can travel abroad instantly – as single-dose vaccine was discovered to ‘neutralize’ the variant Delta News from UK


Johnson & Johnson vaccine ‘neutralizes’ Delta variant, new study finds

A ray of hope has been provided in the quest to prevent the highly contagious Delta variant from triggering a damaging third wave in the UK and elsewhere in the world.

Johnson & Johnson reports that its single-injection vaccine has shown great promise against the strain in a lab study.

Analysis of the blood of eight patients showed that the vaccine-induced immune responses against the Delta variant, first identified in India, were at a higher level than against the Beta variant, which was first identified. times in South Africa.

“We believe our vaccine provides long-lasting protection against COVID-19 and triggers neutralizing activity against the Delta variant,” said Johnson & Johnson Scientific Director Paul Stoffels.

J&J submitted the data as a preprint on the bioRxiv website, prior to peer review.

And in another boost, data from a separate study also showed that the immune response of vaccine recipients lasted for at least eight months.

“Johnson & Johnson Single Injection COVID-19 Vaccine Generates Strong Neutralizing Antibody Response That Does Not Weaken; rather we see improvement over time, ”said Mathai Mammen, head of research and development at J & J’s Drugs.

So far, preliminary data has shown that vaccines made by Pfizer, AstraZeneca (AZN.L) and Moderna (MRNA.O) are largely protective against Delta, with the concentration of virus neutralizing antibodies being somewhat reduced.

Previous Marriott Bonvoy invites international travelers to start dreaming of summer in Phuket
Next Thai SEC, Cayman Islands Regulator Take Action Against Binance

No Comment

Leave a reply

Your email address will not be published.